Eugene Durenard - Jan 8, 2023 Form 4 Insider Report for Co-Diagnostics, Inc. (CODX)

Role
Director
Signature
/s/ Eugene Durenard
Stock symbol
CODX
Transactions as of
Jan 8, 2023
Transactions value $
$0
Form type
4
Date filed
1/9/2023, 03:30 PM
Previous filing
Nov 23, 2022
Next filing
Jan 19, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CODX Common Stock Award $0 +12.5K +51.72% $0.00 36.7K Jan 8, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CODX Restricted Stock Units Options Exercise $0 -12.5K -17.65% $0.00 58.3K Jan 8, 2023 Common Stock 70.8K $0.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Included in 37,500 restricted stock units awarded to the Reporting Person on January 8, 2021, pursuant to the Co-Diagnostics, Inc. 2015 Long Term Incentive Plan, and vest in three equal installments every twelve months commencing on January 8, 2021. Included in 70,000 restricted stock units awarded to the Reporting Person on July 11, 2022, pursuant to the Co-Diagnostics, Inc. 2015 Long Term Incentive Plan, and vest in 6 equal installments every 6 months commencing on November 23, 2022.